Us Bancorp \De\ Oyster Point Pharma, Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$3.6 - $11.2 $1,105 - $3,438	-307 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$8.58 - $17.65 $386 - $794	45 Added 17.18%	307 $4,000
Q4 2021 Feb 11, 2022	BUY	$10.17 - $18.96 $1,210 - $2,256	119 Added 83.22%	262 $5,000
Q3 2021 Nov 10, 2021	BUY	$11.67 - $18.07 $1,668 - $2,584	143 New	143 $2,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.